Deaths (1 - 10 of 11 items)
Medical Devices: Cancer Risk Led FDA to Warn Against Certain Uses of Power Morcellators and Recommend New Labeling
GAO-17-231: Published: Feb 7, 2017. Publicly Released: Feb 8, 2017.
Between 1991 and 2014, the Food and Drug Administration (FDA)—the federal agency responsible for the oversight of medical devices—cleared 25 submissions for laparoscopic power morcellators for the U.S. market. FDA cleared the submissions for these devices, which cut tissue into small pieces to facilitate removal through small incision sites of gynecological and other types of minimally invasiv...
National Institutes of Health: Kidney Disease Research Funding and Priority Setting
GAO-17-121: Published: Dec 19, 2016. Publicly Released: Jan 18, 2017.
The National Institutes of Health (NIH), within the Department of Health and Human Services, is the primary federal agency that conducts biomedical research on kidney disease, as well as various other diseases and conditions. NIH's budget—$30 billion in fiscal year 2015—mostly funds extramural research that supports research personnel working at universities, medical schools, and other institu...
Emergency Funding for Ebola Response: Some USAID Reimbursements Did Not Comply with Legislative Requirements and Need to Be Reversed
GAO-17-35: Published: Nov 2, 2016. Publicly Released: Nov 2, 2016.
As of July 1, 2016, the U.S. Agency for International Development (USAID) and the Department of State (State) had obligated 58 percent and disbursed more than one-third of the $2.5 billion appropriated for Ebola activities. In the early stages of the U.S. response in West Africa, USAID obligated $883 million to control the outbreak, and State obligated $34 million for medical evacuations, among ot...
Air Travel and Communicable Diseases: Comprehensive Federal Plan Needed for U.S. Aviation System's Preparedness
GAO-16-127: Published: Dec 16, 2015. Publicly Released: Dec 16, 2015.
All of the 14 airports and 3 airlines GAO reviewed have plans for responding to communicable disease threats from abroad, although the United States lacks a comprehensive national aviation-preparedness plan aimed at preventing and containing the spread of diseases through air travel. U.S. airports and airlines are not required to have individual preparedness plans, and no federal agency tracks whi...
Vaccine Injury Compensation: Most Claims Took Multiple Years and Many Were Settled through Negotiation
GAO-15-142: Published: Nov 21, 2014. Publicly Released: Nov 21, 2014.
Most of more than 9,800 claims filed with the National Vaccine Injury Compensation Program (VICP) since fiscal year 1999 have taken multiple years to adjudicate (see fig.). More than 1,000 (11 percent) of claims filed since fiscal year 1999 were still in process (pending) as of March 31, 2014; most of these were pending for 2 years or less. A greater percentage of the claims filed since fiscal yea...
National Institutes of Health: Fiscal Year 2013 Research Funding Allocations across Selected Diseases and Conditions
GAO-14-490R: Published: Apr 23, 2014. Publicly Released: Apr 30, 2014.
In fiscal year 2013, the National Institutes of Health (NIH) reported research funding levels that ranged widely for the 40 different Research, Condition, and Disease Categorization system (RCDC) categories GAO examined that corresponded to the most frequent causes of death in the United States, the most frequent causes of death globally, and the most prevalent chronic conditions for adults in the...
National Institutes of Health: Research Priority Setting, and Funding Allocations across Selected Diseases and Conditions
GAO-14-246: Published: Mar 31, 2014. Publicly Released: Apr 30, 2014.
Individual institutes and centers (ICs) at the National Institutes of Health (NIH) set their own research priorities, and GAO found that the five selected ICs—awarding the largest amount of research funding—that it reviewed did so considering similar factors and using various priority-setting approaches. Agency officials stated that the ICs' mission and appropriations inform priority-setting a...
Drug Shortages: Threat to Public Health Persists, Despite Actions to Help Maintain Product Availability
GAO-14-339T: Published: Feb 10, 2014. Publicly Released: Feb 10, 2014.
The number of drug shortages remains high. Although reports of new drug shortages declined in 2012, the total number of shortages active during a given year—including both new shortages reported and ongoing shortages that began in a prior year—has increased since 2007. Many shortages are of generic sterile injectable drugs. Provider association representatives reported that drug shortages may...
Workplace Safety and Health: Further Steps by OSHA Would Enhance Monitoring of Enforcement and Effectiveness
GAO-13-61: Published: Jan 24, 2013. Publicly Released: Feb 25, 2013.
The Department of Labor's Occupational Safety and Health Administration (OSHA) provides more frequent monitoring and more consistent guidance for its federal enforcement activities than for state enforcement activities. More specifically, OSHA regional officials review performance reports on federal activities at least every other week but review reports on state-run program activities quarterly....
Influenza: Progress Made in Responding to Seasonal and Pandemic Outbreaks
GAO-13-374T: Published: Feb 13, 2013. Publicly Released: Feb 13, 2013.
GAO's prior work has identified a number of lessons from federal responses to seasonal influenza vaccine shortages and the 2009 H1N1 pandemic that carry implications for future influenza seasons or another influenza pandemic. These lessons include the value of planning that involves the Department of Health and Human Services (HHS); the importance of effective communication among all levels of gov...